Analysts Set BioNTech SE (NASDAQ:BNTX) Target Price at $142.08
Shares of BioNTech SE (NASDAQ:BNTX – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eighteen research firms that are currently covering the company, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation, fourteen have issued a buy recommendation and one has given a strong buy […]
Shares of BioNTech SE (NASDAQ:BNTX – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eighteen research firms that are currently covering the company, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation, fourteen have issued a buy recommendation and one has given a strong buy […]
